NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

Thanks. It was TLD and journal in 2022. Now its Flaskworks & Reimbursements in 2026 (if we are lucky with Flaskworks going according to plan!). I wonder what carrots are left to be dangled another 4 years from then for 2030.

Even my $1.5 share price prediction ($3B market cap at 2B fully diluted by then) seems very optimistic for 2026 given the history here.